Annual Retained Earnings
-$600.66 M
-$130.62 M-27.79%
31 December 2023
Summary:
Tonix Pharmaceuticals Holding annual retained earnings is currently -$600.66 million, with the most recent change of -$130.62 million (-27.79%) on 31 December 2023. During the last 3 years, it has fallen by -$333.13 million (-124.52%). TNXP annual retained earnings is now -2717809.50% below its all-time high of -$22.10 thousand, reached on 31 December 2008.TNXP Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$708.59 M
-$14.21 M-2.05%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding quarterly retained earnings is currently -$708.59 million, with the most recent change of -$14.21 million (-2.05%) on 30 September 2024. Over the past year, it has dropped by -$135.25 million (-23.59%). TNXP quarterly retained earnings is now -7085760.00% below its all-time high of -$10.00 thousand, reached on 31 March 2008.TNXP Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNXP Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.8% | -23.6% |
| 3 y3 years | -124.5% | -114.5% |
| 5 y5 years | -218.7% | -240.1% |
TNXP Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -124.5% | at low | -114.5% | at low |
| 5 y | 5 years | -218.7% | at low | -240.1% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Tonix Pharmaceuticals Holding Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$708.59 M(+2.0%) |
| June 2024 | - | -$694.37 M(+12.8%) |
| Mar 2024 | - | -$615.60 M(+2.5%) |
| Dec 2023 | -$600.66 M(+27.8%) | -$600.66 M(+4.8%) |
| Sept 2023 | - | -$573.34 M(+5.1%) |
| June 2023 | - | -$545.36 M(+5.5%) |
| Mar 2023 | - | -$516.99 M(+10.0%) |
| Dec 2022 | -$470.04 M(+30.6%) | -$470.04 M(+7.2%) |
| Sept 2022 | - | -$438.36 M(+7.1%) |
| June 2022 | - | -$409.38 M(+6.0%) |
| Mar 2022 | - | -$386.24 M(+7.3%) |
| Dec 2021 | -$359.82 M(+34.5%) | -$359.82 M(+8.9%) |
| Sept 2021 | - | -$330.27 M(+5.9%) |
| June 2021 | - | -$311.74 M(+8.2%) |
| Mar 2021 | - | -$288.19 M(+7.7%) |
| Dec 2020 | -$267.53 M(+23.2%) | -$267.53 M(+6.8%) |
| Sept 2020 | - | -$250.51 M(+5.0%) |
| June 2020 | - | -$238.52 M(+6.3%) |
| Mar 2020 | - | -$224.34 M(+3.4%) |
| Dec 2019 | -$217.07 M(+15.2%) | -$217.07 M(+4.2%) |
| Sept 2019 | - | -$208.36 M(+3.9%) |
| June 2019 | - | -$200.53 M(+3.0%) |
| Mar 2019 | - | -$194.69 M(+3.3%) |
| Dec 2018 | -$188.45 M(+16.1%) | -$188.45 M(+4.2%) |
| Sept 2018 | - | -$180.86 M(+3.1%) |
| June 2018 | - | -$175.38 M(+3.6%) |
| Mar 2018 | - | -$169.30 M(+4.3%) |
| Dec 2017 | -$162.36 M(+15.0%) | -$162.36 M(+3.5%) |
| Sept 2017 | - | -$156.87 M(+3.8%) |
| June 2017 | - | -$151.08 M(+3.3%) |
| Mar 2017 | - | -$146.30 M(+3.6%) |
| Dec 2016 | -$141.24 M | -$141.24 M(+5.6%) |
| Sept 2016 | - | -$133.76 M(+6.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2016 | - | -$126.18 M(+8.4%) |
| Mar 2016 | - | -$116.37 M(+13.6%) |
| Dec 2015 | -$102.40 M(+88.4%) | -$102.40 M(+15.0%) |
| Sept 2015 | - | -$89.04 M(+17.5%) |
| June 2015 | - | -$75.79 M(+18.4%) |
| Mar 2015 | - | -$64.03 M(+17.8%) |
| Dec 2014 | -$54.34 M(+103.3%) | -$54.34 M(+19.8%) |
| Sept 2014 | - | -$45.35 M(+19.6%) |
| June 2014 | - | -$37.94 M(+19.0%) |
| Mar 2014 | - | -$31.89 M(+19.3%) |
| Dec 2013 | -$26.73 M(+68.7%) | -$26.73 M(+16.1%) |
| Sept 2013 | - | -$23.02 M(+15.5%) |
| June 2013 | - | -$19.93 M(+11.7%) |
| Mar 2013 | - | -$17.85 M(+12.6%) |
| Dec 2012 | -$15.84 M(+147.8%) | -$15.84 M(+19.9%) |
| Sept 2012 | - | -$13.22 M(+15.1%) |
| June 2012 | - | -$11.48 M(+36.5%) |
| Mar 2012 | - | -$8.41 M(+31.5%) |
| Dec 2011 | -$6.39 M(+118.7%) | -$6.39 M(+7893.4%) |
| Sept 2011 | - | -$80.00 K(+3.0%) |
| June 2011 | - | -$77.70 K(+2.0%) |
| Mar 2011 | - | -$76.20 K(-97.4%) |
| Dec 2010 | -$2.92 M(+5418.1%) | -$2.92 M(+4406.3%) |
| Sept 2010 | - | -$64.90 K(+6.0%) |
| June 2010 | - | -$61.20 K(+4.1%) |
| Mar 2010 | - | -$58.80 K(+10.9%) |
| Dec 2009 | -$53.00 K(+139.8%) | -$53.00 K(+7.1%) |
| Sept 2009 | - | -$49.50 K(+5.5%) |
| June 2009 | - | -$46.90 K(+42.1%) |
| Mar 2009 | - | -$33.00 K(+49.3%) |
| Dec 2008 | -$22.10 K | -$22.10 K(+16.9%) |
| Sept 2008 | - | -$18.90 K(+23.5%) |
| June 2008 | - | -$15.30 K(+53.0%) |
| Mar 2008 | - | -$10.00 K |
FAQ
- What is Tonix Pharmaceuticals Holding annual retained earnings?
- What is the all time high annual retained earnings for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding annual retained earnings year-on-year change?
- What is Tonix Pharmaceuticals Holding quarterly retained earnings?
- What is the all time high quarterly retained earnings for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding quarterly retained earnings year-on-year change?
What is Tonix Pharmaceuticals Holding annual retained earnings?
The current annual retained earnings of TNXP is -$600.66 M
What is the all time high annual retained earnings for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high annual retained earnings is -$22.10 K
What is Tonix Pharmaceuticals Holding annual retained earnings year-on-year change?
Over the past year, TNXP annual retained earnings has changed by -$130.62 M (-27.79%)
What is Tonix Pharmaceuticals Holding quarterly retained earnings?
The current quarterly retained earnings of TNXP is -$708.59 M
What is the all time high quarterly retained earnings for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high quarterly retained earnings is -$10.00 K
What is Tonix Pharmaceuticals Holding quarterly retained earnings year-on-year change?
Over the past year, TNXP quarterly retained earnings has changed by -$135.25 M (-23.59%)